Reuters logo
BRIEF-‍Epigenomics announces recent payment decision by CMS​
November 21, 2017 / 9:42 PM / in 25 days

BRIEF-‍Epigenomics announces recent payment decision by CMS​

Nov 21 (Reuters) - Epigenomics AG

* Epigenomics AG announces recent payment decision by CMS​

* Epigenomics - CMS has changed pricing determination for Epi proColon(R), only fda-approved blood-based test for colorectal cancer (CRC) screening​

* Epigenomics - ‍CMS agreed original “crosswalk” determination was not appropriate and reimbursement for Epi proColon should be determined by “gapfilling”​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below